Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).

How to manage a Trulicity® (dulaglutide) overdose?

In the event of overdose, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms.

UK_cFAQ_GLP024_OVERDOSE
UK_cFAQ_GLP024_OVERDOSE
en-GB

Symptoms of dulaglutide overdose

Effects of overdose with dulaglutide in clinical studies have included

  • gastrointestinal disorders and
  • hypoglycaemia.1

References

1Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Date of Last Review: 07 July 2020


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request